Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980698567> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2980698567 endingPage "5024" @default.
- W2980698567 startingPage "5024" @default.
- W2980698567 abstract "Abstract Acquired hemophilia due to inhibitor antibodies is a rare entity during childhood period. Moreover, transplacental hemophilia during the newborn period as a result of maternal IgG antibodies (inhibitors) which may cross the placenta into the foetal circulation is very rare and may cause life- threathening neonatal hemorrhages. The occurence of acquired hemophilia during or after delivery may lead bleeding tendencies in both the mother and baby. Here, we want to decribe a newborn baby who delivered from a mother with an initial diagnosis of acquired Hemophilia A and succesfully treated with a prohylactic rFVIIa. Case : A 27 years old women who was diagnosed with an acquired hemophilia A after her first delivery was admitted to our hospital for the second delivery.Her pregnancies were 15 months apart. Her FVIII level was found to be low (<1%) with a very high titer (>100NBU) inhibitor.She was treated with rFVIIa before C/S by adult hematologist and after giving a birth to a term boy without any bleeding complication, newborn baby was referred to our department because of having low FVIII level (0.3 %) with high titer inhibitor(320 NBU) and an abnormal aPTT mixing test on the first day of life. Cranial and abdominal USG was found to be normal and despite having no bleeding event we decide to give IVIG treatment due to very high titer of inhibitor level. On the 3rd day of life some blood in the stool was detected however there is no decrease in the Hb level. Prophylactic rFVIIa with a dose of 90µg/kg/daily was given during the next 4 weeks and inhibitor level was checked regulary. His inhibitor level was decraesed gradually on the first week 256NBU , second week 51 NBU and 4th week 2NBU with a FVIII level 2.7% and propylactic treatment was stopped on the 5th week of life. Although we did not able to detect inhibitor antibodies by trying to do aptt mixing test in the breastmilk, his mother did not have enough breatmilk and baby was supported by infant formula as well. There was a few numbers of cases with neonatal acquired hemophilia due to transplacental transfer of autoantibodies reported in the literature . It was reported that most inhibitors spntaneously disappear over a median 30 months after delivery and FVIII inhibitors are rarely present during labor and delivery in the next pregnancy. However, in our case 15 months after the first pregnacy he was delivered. The outcome of the transplasental acquired hemophilia cases reported in the literature was favorable with a resolution after a median of 3 months (range 0.2-3 months) despite one of them experienced intracranial hemorrhage.. Although peak inhibitor titer was reported to be 150BUin the literature, in our case it was the higher than the reported level (320NBU). However despite a very high peak inhibitor titer, we can speculate that due to limited intake of breastmilk which may also contain inhibitor antibodies may ameoliorate the prompt decrase of inhibitor antibodies. rFVIIa is safe and protect our patient from life-threatening bleeding events without any complication. Disclosures No relevant conflicts of interest to declare." @default.
- W2980698567 created "2019-10-25" @default.
- W2980698567 creator A5018483470 @default.
- W2980698567 creator A5042622002 @default.
- W2980698567 creator A5062266684 @default.
- W2980698567 creator A5063074658 @default.
- W2980698567 date "2018-11-29" @default.
- W2980698567 modified "2023-09-28" @default.
- W2980698567 title "Transplacental Hemophilia a and Prophylactic Treatment with Recombinant FVIIa in the Newborn Period" @default.
- W2980698567 doi "https://doi.org/10.1182/blood-2018-99-119760" @default.
- W2980698567 hasPublicationYear "2018" @default.
- W2980698567 type Work @default.
- W2980698567 sameAs 2980698567 @default.
- W2980698567 citedByCount "0" @default.
- W2980698567 crossrefType "journal-article" @default.
- W2980698567 hasAuthorship W2980698567A5018483470 @default.
- W2980698567 hasAuthorship W2980698567A5042622002 @default.
- W2980698567 hasAuthorship W2980698567A5062266684 @default.
- W2980698567 hasAuthorship W2980698567A5063074658 @default.
- W2980698567 hasConcept C126322002 @default.
- W2980698567 hasConcept C141071460 @default.
- W2980698567 hasConcept C159654299 @default.
- W2980698567 hasConcept C172680121 @default.
- W2980698567 hasConcept C187212893 @default.
- W2980698567 hasConcept C203014093 @default.
- W2980698567 hasConcept C2776953305 @default.
- W2980698567 hasConcept C2778961111 @default.
- W2980698567 hasConcept C2779134260 @default.
- W2980698567 hasConcept C2779234561 @default.
- W2980698567 hasConcept C2779906218 @default.
- W2980698567 hasConcept C2908580079 @default.
- W2980698567 hasConcept C32611913 @default.
- W2980698567 hasConcept C54355233 @default.
- W2980698567 hasConcept C71924100 @default.
- W2980698567 hasConcept C86803240 @default.
- W2980698567 hasConceptScore W2980698567C126322002 @default.
- W2980698567 hasConceptScore W2980698567C141071460 @default.
- W2980698567 hasConceptScore W2980698567C159654299 @default.
- W2980698567 hasConceptScore W2980698567C172680121 @default.
- W2980698567 hasConceptScore W2980698567C187212893 @default.
- W2980698567 hasConceptScore W2980698567C203014093 @default.
- W2980698567 hasConceptScore W2980698567C2776953305 @default.
- W2980698567 hasConceptScore W2980698567C2778961111 @default.
- W2980698567 hasConceptScore W2980698567C2779134260 @default.
- W2980698567 hasConceptScore W2980698567C2779234561 @default.
- W2980698567 hasConceptScore W2980698567C2779906218 @default.
- W2980698567 hasConceptScore W2980698567C2908580079 @default.
- W2980698567 hasConceptScore W2980698567C32611913 @default.
- W2980698567 hasConceptScore W2980698567C54355233 @default.
- W2980698567 hasConceptScore W2980698567C71924100 @default.
- W2980698567 hasConceptScore W2980698567C86803240 @default.
- W2980698567 hasIssue "Supplement 1" @default.
- W2980698567 hasLocation W29806985671 @default.
- W2980698567 hasOpenAccess W2980698567 @default.
- W2980698567 hasPrimaryLocation W29806985671 @default.
- W2980698567 hasRelatedWork W1992363163 @default.
- W2980698567 hasRelatedWork W2002120878 @default.
- W2980698567 hasRelatedWork W2003938723 @default.
- W2980698567 hasRelatedWork W2047967234 @default.
- W2980698567 hasRelatedWork W2118496982 @default.
- W2980698567 hasRelatedWork W2198236399 @default.
- W2980698567 hasRelatedWork W2384634481 @default.
- W2980698567 hasRelatedWork W2439875401 @default.
- W2980698567 hasRelatedWork W2980698567 @default.
- W2980698567 hasRelatedWork W4237124780 @default.
- W2980698567 hasVolume "132" @default.
- W2980698567 isParatext "false" @default.
- W2980698567 isRetracted "false" @default.
- W2980698567 magId "2980698567" @default.
- W2980698567 workType "article" @default.